Product Description
| Synonyms: | LIGNOCAINE HYDROCHLORIDE;LIDOCAINE HYDROCHLORIDE;LIDOCAINE HCL;Lidocaine hydrochloride CP2000,BP98;a-(diethylamino)-26-acetoxylidideHCl;a-(diethylamino)-26-acetoxylididehydrochloride;Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, 2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide hydrochloride |
| CAS NO: | 73-78-9 |
| EINECS: | 200-803-8 |
| Molecular Formula: | C14H23ClN2O |
| Molecular Weight: | 270.798 |
| Density | N/A |
| Melting Point: | 80-82°C |
| Boiling point: | 350.8ºC at 760 mmHg |
| Flash Point | 166ºC |
| Appearance: | white powder |
Product Picture
Product Usage
Lidocaine hydrochloride is characterized by strong penetration, strong dispersion, rapidly onset. The anesthetic performance is twice that of procaine and the toxicity is1. There is an anesthetic effect after 5 minutes treatments, and anesthesia can last 1 to 1.5 hours, 50% longer than procaine. The drug is effective on the heart of the disease or arrhythmia caused by cardiac glycoside, but on the supraventricular tachycardia is poor. This product is fast and oral ineffective, with short duration, and often used as intravenous administration.
Reviews
There are no reviews yet.